Medicines labeled for the same conditions
Alternatives to aclidinium and formoterol
12 other medicines are given the same way (respiratory (inhalation)) and in the same FDA class as aclidinium and formoterol or labeled mainly for the same use (COPD); 11 are in its class, beta2-adrenergic agonists: fluticasone and salmeterol, albuterol and ipratropium, ipratropium, arformoterol and 7 more; the others include 1 phosphodiesterase 3 inhibitor (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0787 per mL (Ipratropium-albuterol 0.5-3(2.5) mg/3 mL) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as aclidinium and formoterol?
COPD lists all 23 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (respiratory (inhalation)) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Aclidinium and formoterolbeta2-adrenergic agonist | this medicine | none listed | n/a | No | No current entry |
| Fluticasone and salmeterolbeta2-adrenergic agonist · same class | COPD | 8 labelers | $1.07 per unit 100-50 | No | A presentation being discontinued |
| Albuterol and ipratropiumbeta2-adrenergic agonist · same class | COPD | 14 labelers | $0.0787 per mL 0.5-3(2.5) mg/3 mL | No | No current entry |
| Ipratropiumanticholinergic · same class | COPD | 13 labelers | $0.111 per mL 0.02% solution | No | No current entry |
| Arformoterolbeta2-adrenergic agonist · same class | COPD | 15 labelers | $0.633 per mL 15 mcg/2 mL solution | No | No current entry |
| Fluticasone and vilanterolbeta2-adrenergic agonist · same class | COPD | none listed | $3.90 per unit 100-25 | No | No current entry |
| Fluticasone and umeclidinium and vilanterolbeta2-adrenergic agonist · same class | COPD | none listed | $11.12 per unit 100-62.5-25 | No | No current entry |
| Tiotropiumanticholinergic · same class | COPD | none listed | $126.08 per gram 1.25 mcg inhaler | No | No current entry |
| Umeclidinium and vilanterolbeta2-adrenergic agonist · same class | COPD | none listed | $4.95 per inhaler 62.5-25 mcg inhaler | No | No current entry |
| Olodaterolbeta2-adrenergic agonist · same class | COPD | none listed | $65.94 per gram Striverdi respimat inhal spray | No | No current entry |
| Olodaterol and tiotropiumbeta2-adrenergic agonist · same class | COPD | none listed | $115.80 per gram 60) | No | No current entry |
| Revefenacinanticholinergic · same class | COPD | none listed | $17.43 per mL 175 mcg/3 mL solution | No | No current entry |
| Ensifentrinephosphodiesterase 3 inhibitor | COPD | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Aclidinium and formoterol: the full record
- label, generics, price, shortages, recalls